ORBIMED ADVISORS LLC - Director, 10%+ Owner at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
TERN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ORBIMED ADVISORS LLC since 12 Mar 2025

Holdings reported by ORBIMED ADVISORS LLC for Terns Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 755,635 $7,556,350 $10.00 16 Jul 2024 Indirect

Transactions reported by ORBIMED ADVISORS LLC for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.